As PTC prepares to release its Q4 financial results, investors are weighing its strong historical performance against a turbulent market for vertical software stocks. Here’s the breakdown.
CME Group is set to report fourth-quarter earnings Wednesday morning, with analysts forecasting a 7.8% revenue increase. The derivatives exchange operator's performance may signal broader capital markets health as peers post mixed results.
The global electronics manufacturer is poised to release its quarterly results Wednesday, with investors watching for signs of stabilization after a period of revenue contraction.
Nomura Holdings announces a significant share buyback program while tightening risk controls at its digital asset unit, Laser Digital. The move signals a dual focus on immediate capital returns and long-term, regulated growth in the crypto space, as the financial giant navigates a volatile market.
Tenable Holdings, a leader in exposure management, reports its fourth-quarter earnings after the bell Wednesday. All eyes will be on whether the company can maintain its track record of revenue beats against a backdrop of slowing growth forecasts and a battered cybersecurity sector.
Payment technology firm WEX Inc. is set to release its quarterly financial results after Wednesday's market close, with Wall Street anticipating a return to revenue growth following last year's dip.
Samsung Electronics unveils enhanced privacy controls for Galaxy devices and a special Olympic Edition of its foldable phone, aiming to bolster its brand in security and high-profile partnerships while its shares show significant long-term gains.
Arcellx shares have delivered stellar multi-year gains, prompting investors to question if the rally still has room to run. A deep dive into valuation metrics reveals a complex picture, with discounted cash flow models pointing to significant upside while price-to-book ratios suggest a more cautious stance.
Silgan Holdings is set to report fourth-quarter earnings Wednesday morning, with Wall Street eyeing slowing revenue growth and the company's ability to outperform in a mixed industrial packaging landscape.
Eli Lilly's $3.5 billion investment in a new Pennsylvania facility for injectable weight-loss drugs, including retatrutide, spotlights its aggressive expansion in the obesity market. This strategic move, coupled with strong analyst sentiment and upcoming earnings, intensifies focus on the company's growth trajectory and premium valuation.
Amgen has terminated its collaboration with Kyowa Kirin on the atopic dermatitis drug rocatinlimab, handing full development rights back to the Japanese partner. The strategic shift comes as Amgen's stock trades above most fair value estimates, raising questions about its current valuation amid pipeline recalibration.
Shares of cybersecurity firm Gen Digital have tumbled over 7% in a week, pushing its valuation metrics below industry averages. A deep dive into its cash flows and earnings multiples suggests the market may be undervaluing the consumer digital safety provider.
Shares of Coastal Financial (CCB) have tumbled over 13% in the past month, sparking debate among investors. While a proprietary valuation model suggests the stock is deeply undervalued, its premium P/E ratio tells a conflicting story. We examine the numbers and the broader context for regional banks.
Energy Recovery (ERII) sees its price target raised to $23 by analysts, reflecting increased confidence in the adoption timeline for its CO2 refrigeration technology, despite stable core valuation metrics. The shift underscores a nuanced market narrative focused on execution rather than a fundamental change in long-term prospects.
Stanley Black & Decker announces key leadership changes, appointing a new General Counsel and adding fresh expertise to its board. The moves signal a deeper focus on governance and operational oversight as the company navigates its financial turnaround.
Compass Point Research suggests the prolonged cryptocurrency downturn may be nearing its end, with Bitcoin finding a potential bottom around $60,000-$68,000 unless broader market turmoil intervenes.
A Wells Fargo upgrade highlights ConocoPhillips' robust cash flow trajectory and strategic projects, positioning the energy giant for significant dividend growth over the next five years.
Palantir Technologies' stock surged after hours as the data analytics firm reported record quarterly results, fueled by its AI platform. CEO Alex Karp hailed an 'iconic' performance while warning that the company's dominance creates societal and political tensions.
Vera Therapeutics appoints industry veteran Matt Skelton as Chief Commercial Officer, signaling a strategic pivot toward commercialization as its lead drug candidate for IgA nephropathy, atacicept, undergoes FDA Priority Review.
Kemper Corporation is set to report its fourth-quarter earnings Wednesday afternoon, with investors watching closely for signs of stability after a period of mixed performance and sector-wide pressure.
